Life Biosciences
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
75 Park Plz Ste 3, Boston, Massachusetts...Phone Number
(857) 400-9245Website
www.lifebiosciences.comRevenue
$5.9 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
2
About Life Biosciences
Life Biosciences is viewed by third parties as a clinicalstage biotechnology company focused on developing cellular rejuvenation and agerelated disease therapies by targeting the fundamental biology of aging. It pioneers approaches such as partial epigenetic reprogramming to reverse and prevent ageassociated conditions, advancing therapeutic candidates from research into clinical evaluation. The company operates at the intersection of longevity science and translational medicine, aiming to extend healthy human lifespan and address chronic diseases driven by aging rather than isolated symptoms. Headquartered in Boston, Massachusetts, USA, it was founded by scientists including DavidA.Sinclair and builds on collaborative research to translate cuttingedge biology into potential treatments.Explore more
Life Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Life Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Life Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Life Biosciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Life Biosciences had a recent Job posting/layoffs
Life Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Life Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Life Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Life Biosciences has new funding data
Product Launch: Get notified when Life Biosciences launches new products
Recommended Actions
Find VP level buyers at Life Biosciences
Find 3 more new buyers
Compare Similar Companies to Life Biosciences
Compare insights from companies similar to Life Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Life Biosciences
$5.9M
11-50
Private
$111M
2017
Amit ShashankChief Administrative Officer & General Counsel
Company Profile Activity
Activity Insights
Life Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Life Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Life Biosciences.
Life Biosciences financials insights
Gather financial insights about Life Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series D
$80M
Stock/Share Issuance
$31M
Life Biosciences Tech Stack
A closer look at the technologies used by Life Biosciences
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Life Biosciences News & Media
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
Lead epigenetic restoration therapy enters the clinic for glaucoma and NAION, targeting a root cause of age-related vision lossLife Biosciences Secures $80 Million Series D Financing
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platformLife Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human clinical trials IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human clinical trialsLife Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors
Life Bio adds accomplished biotech leader to its Board as the company prepares for an early 2026 initiation of human trials Life Bio adds accomplished biotech leader to its Board as the company prepares for an early 2026 initiation of human trials
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Life Biosciences
Sign Up For FreeTo access detailed company insights
Life Biosciences is viewed by third parties as a clinicalstage biotechnology company focused on developing cellular rejuvenation and agerelated disease therapies by targeting the fundamental biology of aging. It pioneers approaches such as partial epigenetic reprogramming to reverse and prevent ageassociated conditions, advancing therapeutic candid... Read More
